Company

UNITY Biotechnology, Inc.

Source-reviewedGoverned LongevityNext intelligence profile

Evidence reviewed through2026-08-07

Executive intelligence snapshot

Current reviewed view

A reviewed company profile connected to UBX1325, UBX0101, UBX1325 ENVISION wet-AMD Phase 2, and UBX0101 Phase 2 knee osteoarthritis in the current LongevityNext intelligence graph.

This profile includes 4 reviewed relationship(s) and 9 reviewed source(s).

This view is bounded by reviewed evidence and does not provide a recommendation or a claim beyond the stated review date.

Evidence state

Source-reviewed

Evidence reviewed through2026-08-07

Evidence state

What the evidence supports

UNITY Biotechnology, Inc.

Evidence boundary

Key limitations

Interpretation remains bounded to this reviewed profile and does not support broader inference.
Does not establish efficacy, mechanism falsification, approval, utility, rejuvenation, or investment attractiveness.

Not established

Key unknowns

Program-level outcomes outside this reviewed profile remain unknown; absence is not a negative finding.
The reviewed evidence does not resolve this dimension beyond the recorded boundary.

Next evidence milestone

What would change this view?

A later first-party filing or announcement confirming close, amendment, payment, termination, or rights change.

Evidence reviewed through 2026-08-07.

Intelligence connections

Develops or sponsors

UBX1325

Intervention

Develops or sponsors

UBX0101

Intervention

UBX1325 ENVISION wet-AMD Phase 2

Trial

UBX0101 Phase 2 knee osteoarthritis

Trial

Reviewed source layer

Evidence & sources

These cards show only metadata present in the reviewed source registry.

Reviewed source

Reviewed source metadata is limited.

bibliographic index

Multifocal Electroretinography Changes after UBX1325 Treatment in Neovascular Age-Related Macular Degeneration

PubMed

Reference: 39337030

Reviewed: 2026-08-06

Reviewed source

Reviewed source metadata is limited.

bibliographic index

Therapeutic subtypes of knee osteoarthritis: differential treatment effects among predicted endotypes

PubMed

Reference: 42092979

Reviewed: 2026-08-06

Reviewed source

Reviewed source metadata is limited.

Reviewed source

Reviewed source metadata is limited.

trial registry

UBX0101 in Patients With Painful Osteoarthritis of the Knee

ClinicalTrials.gov

Reference: NCT04129944

Reviewed: 2026-08-06

filing system